Implementation of magnesium sulphate as an adjunct to multimodal analgesic approach for perioperative pain control in lumbar laminectomy surgery: A randomized placebo-controlled clinical trial

Clin Neurol Neurosurg. 2020 Oct:197:106091. doi: 10.1016/j.clineuro.2020.106091. Epub 2020 Jul 18.

Abstract

Objective: To investigate the effect of systemic intraoperative administration of magnesium sulphate when used in the context of a multimodal pain management plan on analgesics consumption and pain scores, and perioperative outcomes after lumbar laminectomy surgery.

Methods: Seventy-four patients undergoing lumbar laminectomy were enrolled in this randomized, double-blind, placebo-controlled trial. Participants were randomly allocated to receive magnesium (20 mg/kg iv given as bolus before anesthesia induction followed by 20 mg/kg/h civ until surgery completion) or saline. Hemodynamic variables and desflurane consumption were noted at predefined time-intervals intraoperatively. Primary outcome was postoperative cumulative analgesic consumption over 24 h, while pain intensity (assessed by Visual Analogue Scale [VAS] at 1, 2, 4, 6 and 24 h), intraoperative hemodynamics and opioid requirements, recovery profile, time to first analgesic request, and adverse effects constituted secondary end-points.

Results: Demographics, surgery duration, desflurane requirements, and recovery profile were comparable between groups. Magnesium attenuated hemodynamic response during incision and emergence from anesthesia. Postoperative analgesics consumption in morphine iv equivalents (mean difference -9.24 [95 %CI -13.31, -5.17] mg; p = 0.001) and VAS scores at all-time points of assessment were lower in magnesium group; this effect peaked at 4 h (mean difference -2.15 [95 %CI -3.21,-1.09; p = 0.001]. Magnesium reduced intraoperative remifentanil consumption and prolonged the time-interval to first rescue analgesia (p < 0.01). No notable adverse effects were recorded.

Conclusion: It occurs that magnesium infusion during lumbar laminectomy surgery potentiates perioperative analgesia and reduces analgesic requirements up to 24 h postoperatively. No profound adverse effect on either intraoperative hemodynamics or any other clinically relevant endpoints becomes evident.

Keywords: Analgesics consumption; Lumbar laminectomy; Magnesium sulphate; NMDA antagonist; Pain.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Analgesia / methods*
  • Anesthetics, Local / therapeutic use*
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Humans
  • Laminectomy / adverse effects*
  • Laminectomy / methods
  • Lumbar Vertebrae / surgery*
  • Magnesium Sulfate / therapeutic use*
  • Male
  • Middle Aged
  • Pain Management / methods*
  • Pain Measurement
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / etiology
  • Treatment Outcome

Substances

  • Anesthetics, Local
  • Magnesium Sulfate